Form 4: Precigen COO Rutul Shah Acquires Shares Through Performance Stock Unit Vesting, Sells Shares to Cover Taxes

Precigen's Chief Operating Officer, Rutul Shah, acquired 125,000 shares of common stock through the vesting of performance stock units and sold 47,151 shares to cover income tax obligations.

Summary

• Rutul Shah, the Chief Operating Officer of Precigen, Inc., acquired 125,000 shares of common stock on January 29, 2025.
• These shares were obtained through the vesting of performance stock units (PSUs) that were originally granted on August 28, 2024.
• The vesting was contingent upon the achievement of specific performance conditions.
• On the same day, Mr. Shah also disposed of 47,151 shares of common stock.
• These shares were withheld by Precigen to satisfy income tax obligations related to the vesting of the PSUs.
• The price of the shares sold for tax purposes was $1.30 per share.
• Following these transactions, Mr. Shah directly owns 287,595 shares of Precigen common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The vesting of PSUs suggests performance targets were met, which is good. However, the sale of shares, even for tax purposes, could be viewed with slight caution by some investors.

Positives

• The vesting of performance stock units indicates that performance goals were met, which is a positive sign for the company.
• The acquisition of 125,000 shares increases the COO's stake in the company, aligning his interests with shareholders.

Negatives

• The sale of 47,151 shares, while for tax purposes, could be perceived negatively by some investors as a reduction in the COO's holdings.

Risks

• The sale of shares, even for tax purposes, could create short-term selling pressure on the stock.
• The market may react negatively to insider selling, regardless of the reason.

Industry Context

This type of transaction is common for executives who receive stock-based compensation. It reflects the vesting of previously granted equity awards and the subsequent sale of shares to cover tax liabilities.

Comparison to Industry Standards

• The vesting of performance-based equity awards is a standard practice in the biotechnology industry, aligning executive compensation with company performance.
• Similar transactions are regularly reported by executives at comparable companies such as Intellia Therapeutics and CRISPR Therapeutics, where stock-based compensation is a significant part of executive pay packages.
• The tax withholding process is also standard, with companies often withholding shares to cover the tax obligations of their employees.

Stakeholder Impact

• Shareholders may view the vesting of PSUs as a positive sign of company performance.
• The sale of shares by an executive, even for tax purposes, could cause some short-term concern among shareholders.

Key Dates

Keywords

Precigen, Rutul Shah, performance stock units, PSUs, insider trading, share acquisition, tax withholding, common stock, vesting